FCAR Protein (Transcript Variant 1) (Myc-DYKDDDDK Tag)
Quick Overview for FCAR Protein (Transcript Variant 1) (Myc-DYKDDDDK Tag) (ABIN2713805)
Target
See all FCAR ProteinsProtein Type
Origin
Source
Application
Purity
-
-
Protein Characteristics
- Transcript Variant 1
-
Purification tag / Conjugate
- This FCAR protein is labelled with Myc-DYKDDDDK Tag.
-
Characteristics
-
- Recombinant human CD89 / FCAR (transcript variant 1) protein expressed in HEK293 cells.
- Produced with end-sequenced ORF clone
-
-
Want other Options for this Protein ?
!Discover Our Predefined Custom Proteins and Custom Protein Services!Your project requires further customization? Contact us and discover our custom protein solutions
-
-
-
Application Notes
-
Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays -
Comment
-
The tag is located at the C-terminal.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 50 μg/mL
-
Buffer
- 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.
-
Storage
- -80 °C
-
Storage Comment
- Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.
-
-
- FCAR (Fc Fragment of IgA, Receptor For (FCAR))
-
Alternative Name
- Cd89,fcar
-
Background
- This gene is a member of the immunoglobulin gene superfamily and encodes a receptor for the Fc region of IgA. The receptor is a transmembrane glycoprotein present on the surface of myeloid lineage cells such as neutrophils, monocytes, macrophages, and eosinophils, where it mediates immunologic responses to pathogens. It interacts with IgA-opsonized targets and triggers several immunologic defense processes, including phagocytosis, antibody-dependent cell-mediated cytotoxicity, and stimulation of the release of inflammatory mediators. Multiple alternatively spliced transcript variants encoding different isoforms have been described for this gene.
-
Molecular Weight
- 29.9 kDa
-
NCBI Accession
- NP_001991
Target
-